Distinguished in Chronic Obstructive Pulmonary Disease (COPD)

Maeva Zysman

Inserm U955 IMRB, UMR U955, Équipe 04, Et Université Paris Est, 
Creteil, FR 
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Inserm U955 IMRB, UMR U955, Équipe 04, Et Université Paris Est, 
Creteil, FR 
OverviewLocationsClinical Research

Overview

Maeva Zysman practices in Creteil, France. Ms. Zysman is rated as a Distinguished expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Artery Agenesis, Emphysema, and Cerebral Hypoxia.

Her clinical research consists of co-authoring 95 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 60 articles and participated in 1 clinical trial in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Female

Locations

Inserm U955 IMRB, UMR U955, Équipe 04, Et Université Paris Est, Creteil, 94010, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases
Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

95 Total Publications

The Healthcare Resource Utilization of Patients with Refractory Chronic Cough Compared to Those with Non-Refractory Chronic Cough.
The Healthcare Resource Utilization of Patients with Refractory Chronic Cough Compared to Those with Non-Refractory Chronic Cough.
Journal: Lung
Published: August 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zysman's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile